Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso;Les polyneuropathies chez les patients traités par les ARV au CHU de Bobo-Dioulasso, Burkina Faso

Bulletin de la Societe de Pathologie Exotique

Volumn 101, Issue 1, 2008, Pages 11-13

  Millogo, A ^a   Lankoande D ^a   Yameogo I ^a   Yameogo A A ^a   Sawadogo, A B ^a  

^a CHU Souro Sanou   (Burkina Faso)

Author keywords

Antiretroviral therapy; Burkina Faso; HIV infection; Hospital; Polyneuropathy; Sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOXAZINE DERIVATIVE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE;

ADULT; ARTICLE; BURKINA FASO; CD4 LYMPHOCYTE COUNT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FOLLOW UP; FOOT DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPESTHESIA; MALE; MIDDLE AGED; PAIN; PARESTHESIA; PATHOLOGICAL REFLEX; PERCEPTIVE THRESHOLD; PHYSIOLOGY; POLYNEUROPATHY; VIBRATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; BURKINA FASO; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; FOOT DISEASES; HIV INFECTIONS; HUMANS; HYPESTHESIA; LAMIVUDINE; MALE; MIDDLE AGED; NEVIRAPINE; PAIN; PARESTHESIA; POLYNEUROPATHIES; REFLEX, ABNORMAL; SENSORY THRESHOLDS; STAVUDINE; VIBRATION;

EID: 39749110626     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. DALAKAS MC - Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst, 2001, 6, 14-20.
2. DE LA MONTE SM, GABUZDA DH, HO DD, BROWN JR RH, HEDLEY-WHYTE T et al. - Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol, 1988, 23, 485-492.
3. FERRARI S, VENTO S, MONACO S, CAVALLARO T, CAINELLI F et al. - Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc, 2006, 81, 213-219.
4. GASTAUT JL - Neuropathies périphériques 2000, In: MRÉJEN S, MOULIGNIER A. Atteintes neurologiques et infection par le VIH. Ed. Médecine-Flammarion Sciences, pp. 138-143.
5. LANTÉRI-MINET M & DESNUELLE C - Douleurs neuropathiques, 2000. In: MRÉJEN S, MOULIGNIER A. Atteintes neurologiques et infection par le VIH. Ed. Médecine-Flammarion Sciences, pp. 154-160.
6. LICHTENSTEIN KA, ARMON C, BARON A, MOORMAN AC, WOOD KC et al. - Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005, 40, 148-157.
7. MILLOGO A, KI-ZERBO GA, SAWADOGO AB, OUEDRAOGO I, YAMEOGO A et al. - Manifestations neurologiques associées à l'infection par le VIH au Centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot, 1999, 92, 23-26.
8. MILLOGO A, SAWADOGO AB, SAWADOGO AP, LANKOANDE D - Neuropathies périphériques révélatrices de l'infection par le VIH au Centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot, 2002, 95, 27-30.
9. MORGELLO S, ESTANISLAO L, SIMPSON D, GERACI A & DIROCCO A - HIV-associated distal polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol, 2004, 61, 546-551.
10. MOULONGUET A - Neuropathies périphériques au cours de l'infection par le VIH. Rev Neurol (Paris), 2003, 159, 1223-1226.
11. MOULONGUET A, LÉGER J-M - Neuropathies périphériques au cours de l'infection par le VIH. 2003. In: Bouche P, Léger J-M, Vallat J-M. Neuropathies périphériques, polyneuropathies et mononeuropathies multiples. Doin Eds, pp. 237-249.
12. MOYLE GJ & SADLER M - Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf, 1998, 19, 481-494.
13. NAKASUJJA N, MUSISI S, ROBERTSON K, WONG M, SACKTOR N & RONALD A - Human immunodeficiency virus neurological complications: An overview of the Ugandan experience. J Neurovirology, 2005, 11, 26-29.
14. von OOSTERHOUT JJ, BODASING N, KUMWENDA JJ, NYIRENDA C, MALLEWA J et al. - Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health, 2005, 10, 464-470.
15. PARRY O, MIELKE J, LATIF AS, RAY S, LEVY LF, SIZIYA S - Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol Scand, 1997, 96, 218-222.
16. PELTIER AC & RUSSELL JW - Advances in understanding drug-induced neuropathies. Drug Saf, 2006, 29, 23-30.
17. PETTERSEN JA, JONES G, WORTHINGTON C et al. - Sensory neuropathy in human immunodeficiency virus/Acquired Immunodeficiency Syndrome patients: protease inhibitor - mediated neurotoxicity. Ann Neurol, 2006, 59, 816-824.
18. SACKTOR N - The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol, 2002, 8, 115-121.
19. SCHIFITTO G, MCDERMOTT MP, MCARTHUR JC, MARDER K, SACKTOR N, et al. - Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology, 2002, 58, 1764-1768.
20. SIMPSON DM - Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol, 2002, 8, 33-41.
21. VERMA A - Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst, 2001, 6, 8-13.
22. VERMA S, ESTANISLAO L S SIMPSON D - HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs, 2005, 19, 325-334.
23. VERMA S, MIESA E, ESTANISLAO L & SIMPSON D - Neuromuscular complications in HIV. Curr Neurol Neurosci Rep, 2004, 4, 62-67.
24. WESTER CW, KIM S, BUSSMANN H, AVALOS A, NDWAPI N et al. - Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr, 2005, 40, 336-343.
25. WILLIAMS D, GERACI A, SIMPSON DM - AIDS and AIDS-treatment neuropathies. Curr Neurol Neurosci Rep, 2001, 1, 533-538.
26. WULFF EA WANG AK, SIMPSON DM - HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs, 2000, 59, 1251-1260.